Home » Topics » Conferences

Conferences
RSS

Preclinical results indicate that nefiracetam may have anticonvulsant effects

Oct. 25, 1999

News from AAO/PAAO joint meeting: droperidol may be indicated for glaucoma

Oct. 25, 1999

Orally active DPP-IV inhibitor presented at EASD meeting heads for clinic

Oct. 22, 1999

Preclinical data for FTY-720 presented at recent Japanese meetings

Oct. 22, 1999

The antidementia drug donepezil may also be beneficial in Lewy body dementia

Oct. 21, 1999

EASD highlights: novel aldose reductase inhibitor effective in model of diabetic neuropathy

Oct. 21, 1999

Potent new methylprednisolone and betamethasone derivatives show promise for asthma

Oct. 20, 1999

Zopolrestat: first report of reversal of preexisting renal hyperperfusion for ARI

Oct. 19, 1999

Texas Biotechnology announces new preclinical, clinical data and future plans for sitaxsentan

Oct. 19, 1999

EASD news: mechanisms of glucose-dependent insulinotropic action of JTT-608 elucidated

Oct. 19, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...